Abstract
In recent years a number of genetic heart diseases have been recognized that can be complicated by malignant arrhythmias leading to sudden death [1]. These genetic diseases can be divided into two groups: (1) channelopathies (congenital dysfunction of cellular ion-channels without macroscopic heart disease) and (2) genetic cardiomyopathies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sarkozy A, Brugada P (2005) Sudden cardiac death and inherited arrhythmia syndromes. J Cardiovasc Electrophysiol 16:S8–S20
Jervell A, Lange-Nielsen F (1957) Congenital deaf mutism, functional heart disease with prolongation of the QT interval and sudden death. Am Heart J 54:59–68
Romano C, Gemme G, Pongiglione R (1963) Aritmie cardiache rare dell’età pediatrica, II: accessi sincopali per fibrillazione ventricolare parossistica. Clin Pediatr (Bologna) 45:656–683
Schwartz PJ (1985) Idiopathic long QT syndrome: progress and questions. Am Heart J 109:399–411
Marks ML, Trippel DL, Keating MT (1995) Long QT syndrome associated with syndactyly identified in females. Am J Cardiol 76:744–745
Duggal P, Vesely MR, Wattanasirichaigoon D et al (1998) Mutation of the gene for IsK associated with both Jervell and Lang-Nielsen and Romano-Ward forms of long QT syndromes. Circulation 97:142–146
Locati EH, Zareba W, Moss AJ et al (1998) Age-and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation 97:2237–2244
Priori SG, Schwartz PJ, Napolitano C et al (2003) Risk stratification in the long-QT syndrome. N Engl J Med 348:1866–1874
Napolitano C, Bloise R, Priori S (2006) Long QT syndrome and short QT syndrome: how to make correct diagnosis and what about eligibility for sport activity. J Cardiovasc Med 7:250–256
Gaita F, Giustetto C, Bianchi F et al (2003) Short QT syndrome. A familial cause of sudden death. Circulation 108:965–970
Brugada R, Hong K, Dumaine R et al (2004) Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 109:30–35
Brugada P, Brugada J (1992) Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol 20:1391–1396
Brugada R, Brugada J, Antzelevitch C et al (2000) Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 101:510–515
Brugada P, Brugada R, Mont L et al (2003) Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart. J Cardiovas Electrophysiol 14:455–457
Priori SG, Napolitano C, Gasparini M et al (2002) Natural history of Brugada syndrome. Insight for risk stratification and management. Circulation 105:1342–1347
Antzelevitch C, Brugada P, Borggrefe M et al (2006) Brugada syndrome. Report of the second consensus conference. Circulation 111:659–670
Delise P, Marras E, Bocchino M (2006) Brugada-like electrocardiogram pattern: how to stratify the risk for sudden cardiac death. Is sport activity contraindicated? J Cardiovasc Med 7:239–245
Coumel P, Fidelle J, Lucet V et al (1978) Catecholaminergic-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children: report of four cases. Br Heart J 40:28–37
Leenhardt A, Lucet V, Denjoy I et al (1995) Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 91:1512–1519
Gasparini M, Priori S, Mantica M et al (2002) Programmed electrical stimulation in Brugada syndrome: how reproducible are the results? J Cardiovasc Electrophysiol 13:880–887
Kanda M, Shimizu W, Matsuo K et al (2002) Electrophysiologic characteristics and implications of induced ventricular fibrillation in symptomatic patients with Brugada syndrome. J Am Coll Cardiol 39:1799–1805
Eckardt L, Probst V, Smits JP et al (2005) Long-term prognosis of individuals with right precordial ST-segment elevation Brugada syndrome. Circulation 111:257–263
Brugada J, Brugada R, Brugada P (2003) Determinants of sudden death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation 108:3092–3096
ACC/AHA/ESC (2006) 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death — Executive summary. Eur Heart J 27:2099–2140
Belhassen B, Viskin S, Fish R et al (1999) Effects of electrophysiologic-guided therapy with Class IA antiarrhyhtmic drugs on the long term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome. J Cardiovasc Electrophysiol 10:1301–1312
Hermida JS, Denjoy I, Clerc J et al (2004) Hydroquinidine therapy in Brugada Syndrome. J Am Coll Cardiol 43:1853–1860
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Italia
About this paper
Cite this paper
Delise, P. (2007). Prevention of Sudden Death in Patients with Genetic Arrhythmias. In: Gulizia, M.M. (eds) Current News in Cardiology. Springer, Milano. https://doi.org/10.1007/978-88-470-0636-2_33
Download citation
DOI: https://doi.org/10.1007/978-88-470-0636-2_33
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0635-5
Online ISBN: 978-88-470-0636-2
eBook Packages: MedicineMedicine (R0)